Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation

被引:32
作者
López, D
Gil-Torregrosa, BC
Bergmann, C
Del Val, M
机构
[1] Inst Salud Carlos III, Ctr Nacl Biol Fundamental, E-28220 Madrid, Spain
[2] Univ So Calif, Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Sch Med, Dept Microbiol, Los Angeles, CA 90033 USA
关键词
D O I
10.4049/jimmunol.164.10.5070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigenic peptides derived from viral proteins by multiple proteolytic cleavages are bound by MHC class I molecules and recognized by CTL. Processing predominantly takes place in the cytosol of infected cells by the action of proteasomes. To identify other proteases involved in the endogenous generation of viral epitopes, specifically those derived from proteins routed to the secretory pathway, we investigated presentation of the HIV-1 ENV 10-mer epitope (318)RGPGRAFVTI(327) (p18) to specific CTL in the presence of diverse protease inhibitors. Both metalloproteinase and proteasome inhibitors decreased CTC recognition of the p18 epitope expressed from either native gp160 or from a chimera based on the hepatitis B virus secretory core protein as carrier protein. Processing of this epitope from both native ENV and the hepatitis B virus secretory core chimeric protein appeared to proceed by a TAP-dependent pathway that involved sequential cleavage by proteasomes and metallo-endopeptidases; however, other protease activities could replace the function of the lactacystin-sensitive proteasomes. By contrast, in a second TAP-independent pathway we detected no contribution of metallopeptidases for processing the ENV epitope from the chimeric protein, These results show that, in the classical TAP-dependent MHC class I pathway, endogenous Ag processing of viral proteins to yield the p18 10-mer epitope requires metallo-endopeptidases in addition to proteasomes.
引用
收藏
页码:5070 / 5077
页数:8
相关论文
共 55 条
[1]   ENVELOPE PROTEIN AND P18(IIIB) PEPTIDE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES FROM HUMANS IMMUNIZED WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE [J].
ACHOUR, A ;
PICARD, O ;
MBIKA, JP ;
WILLER, A ;
SNART, R ;
BIZZINI, B ;
CARELLI, C ;
BURNY, A ;
ZAGURY, D .
VACCINE, 1993, 11 (07) :699-701
[2]   CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR HIV-1 GP160 ANTIGEN AND SYNTHETIC P18III(B) PEPTIDE IN AN HLA-A11-IMMUNIZED INDIVIDUAL [J].
ACHOUR, A ;
LEMHAMMEDI, S ;
PICARD, O ;
MBIKA, JP ;
ZAGURY, JF ;
MOUKRIM, Z ;
WILLER, A ;
BEIX, F ;
BURNY, A ;
ZAGURY, D .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (01) :19-25
[3]   Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of major histocompatability complex class I-restricted peptides from the endoplasmic reticulum to the cytosol [J].
Bacik, I ;
Snyder, HL ;
Anton, LC ;
Russ, G ;
Chen, WS ;
Bennink, JR ;
Urge, L ;
Otvos, L ;
Dudkowska, B ;
Eisenlohr, L ;
Yewdell, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :479-487
[4]  
BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P989
[5]   Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase [J].
Beninga, J ;
Rock, KL ;
Goldberg, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :18734-18742
[6]   AN ENDOGENOUSLY SYNTHESIZED DECAMER PEPTIDE EFFICIENTLY PRIMES CYTOTOXIC T-CELLS SPECIFIC FOR THE HIV-1 ENVELOPE GLYCOPROTEIN [J].
BERGMANN, C ;
STOHLMANN, SA ;
MCMILLAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (11) :2777-2781
[7]  
Bergmann CC, 1996, J IMMUNOL, V157, P3242
[8]  
BERGMANN CC, 1994, J IMMUNOL, V152, P5603
[9]   EXPRESSION OF THE HTLV-III ENVELOPE GENE BY A RECOMBINANT VACCINIA VIRUS [J].
CHAKRABARTI, S ;
ROBERTGUROFF, M ;
WONGSTAAL, F ;
GALLO, RC ;
MOSS, B .
NATURE, 1986, 320 (6062) :535-537
[10]  
CHOPPIN J, 1991, J IMMUNOL, V147, P569